4//SEC Filing
Mills Mike 4
Accession 0001127602-09-016055
CIK 0000882796other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:56 PM ET
Size
14.9 KB
Accession
0001127602-09-016055
Insider Transaction Report
Form 4
Mills Mike
Principal Accounting Officer
Transactions
- Exercise/Conversion
Emp. Stock Option (Right to Buy)
2009-07-23−1,500→ 4,275 totalExercise: $3.26From: 2009-03-14Exp: 2018-03-14→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2009-07-23$3.26/sh+1,500$4,890→ 1,500 total - Sale
Common Stock
2009-07-23$8.26/sh−1,500$12,390→ 0 total
Holdings
- 12,969
Emp. Stock Option (Right to Buy)
Exercise: $5.71From: 2006-01-05Exp: 2015-01-05→ Common Stock (12,969 underlying) - 0
Common Stock
- 6,000
Emp. Stock Option (Right to Buy)
Exercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (6,000 underlying) - 4,000
Emp. Stock Option (Right to Buy)
Exercise: $4.34From: 2006-06-15Exp: 2015-06-15→ Common Stock (4,000 underlying) - 7,832
Emp. Stock Option (Right to Buy)
Exercise: $12.26From: 2007-05-17Exp: 2016-05-17→ Common Stock (7,832 underlying) - 8,361
Emp. Stock Option (Right to Buy)
Exercise: $7.98From: 2008-05-16Exp: 2017-05-16→ Common Stock (8,361 underlying)
Footnotes (1)
- [F1]Stock option exercised and shares sold pursuant to a Rule 10b5-1 plan.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001452496
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 4:56 PM ET
- Size
- 14.9 KB